ACQUIRED · 2024
Who Acquired OPKO / BioReference Clinical Diagnostics Business?
Labcorp · $237.6M
The acquisition
OPKO / BioReference Clinical Diagnostics Business was acquired by Labcorp in 2024 for $237.6M. at 2.40× revenue.
OPKO / BioReference Clinical Diagnostics Business at time of acquisition
Revenue
$100.0M
Deal value
$237.6M
Other acquisitions by Labcorp
Recent transactions by the same buyer — useful for understanding their playbook and what they typically pay.
- OPKO / BioReference Health (Clinical Diagnostics Business) · 2025 · $192.5M
Similar laboratory services acquisitions
- GeneSeek (Neogen Animal Genomics) · acquired by Zoetis in 2026 · $160.0M
- CHS Outreach Laboratory Assets · acquired by Laboratory Corporation of America Holdings in 2025 · $194.5M
- OPKO / BioReference Health (Clinical Diagnostics Business) · acquired by Labcorp in 2025 · $192.5M
- Akoya Biosciences, Inc. · acquired by Quanterix Corporation in 2025 · $286.0M
- Enzo Biochem, Inc. · acquired by Battery Ventures in 2025 · $37.0M
Run a valuation for a similar laboratory services business
Three fields, instant range, backed by 25,592 real M&A transactions including this one.
Open the laboratory services calculator →More on laboratory services valuations
- Laboratory Services valuation calculator· head-term variant
- Laboratory Services median multiples· real-deal benchmarks
- How to value a laboratory services· long-form guide
Sourced from SEC filings and press releases. Full deal page.
Citation: ExitValue.ai. (2024). OPKO / BioReference Clinical Diagnostics Business acquired by Labcorp. https://exitvalue.ai/acquired/opko-bioreference-clinical-diagnostics-business